ストックスクリーナーアプリを入手
6.77
11.06%
-0.96
前日終値:
$7.73
開ける：
$7.37
24時間の取引高:
50,538
Relative Volume:
0.02
時価総額：
$7.16M
収益：
-
当期純損益:
$-1.13M
株価収益率:
-0.1184
EPS:
-57.1626
ネットキャッシュフロー:
$-2.63M
1週間 パフォーマンス:
-38.56%
1か月 パフォーマンス:
+80.19%
6か月 パフォーマンス:
+66.57%
1年 パフォーマンス:
-99.72%
1日の値動き範囲:
$6.66
$7.37
1週間の範囲:
$6.66
$11.26
52週間の値動き範囲:
$2.88
$4,200.00
Polyrizon Ltd Stock (PLRZ) Company Profile
PLRZ を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PLRZ
Polyrizon Ltd
|
6.875 | 8.05M | 0 | -1.13M | -2.63M | -57.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.56 | 116.79B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 81.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.72 | 53.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
848.20 | 52.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
173.49 | 37.48B | 447.02M | -1.18B | -906.14M | -6.1812 |
Polyrizon Ltd (PLRZ) 最新ニュース
What risks investors should watch in Polyrizon Ltd. stockWeekly Trade Report & Free Weekly Watchlist of Top Performers - Улправда
Aug Drivers: What risks investors should watch in Polyrizon Ltd. stock2025 Growth vs Value & Capital Protection Trade Alerts - Улправда
Polyrizon submits pre-request for designation to FDA for PL-16 viral blocker - marketscreener.com
Polyrizon Files FDA Pre-Request for Designation of PL-16 Intranasal Viral Blocker - TipRanks
Polyrizon Submits Pre-Request for Designation to FDA for PL-16 Viral Blocker Designed to Reduce the Exposure to Influenza and Cold Viruses - The Manila Times
Polyrizon Submits Pre-Request for Designation to FDA - One News Page
Is Polyrizon Ltd. stock undervalued vs historical averagesEarnings Growth Summary & Real-Time Market Sentiment Alerts - bolumsonucanavari.com
Winners Losers: Can Polyrizon Ltd stock attract ESG capital inflows2025 AllTime Highs & Breakout Confirmation Trade Signals - moha.gov.vn
Top Medical Stocks To Keep An Eye OnDecember 2nd - MarketBeat
Polyrizon unveils promising results for intranasal naloxone hydrogel - MSN
Resistance Check: Is Polyrizon Ltd stock a buy on dipsShort Setup & Safe Entry Point Identification - moha.gov.vn
Polyrizon completes FDA pre-submission meeting for PL-14 nasal spray - MSN
Polyrizon’s naloxone hydrogel shows positive permeation kinetics - TipRanks
Polyrizon’s intranasal naloxone hydrogel shows promising test results - Investing.com
Polyrizon Unveils Promising Results for Intranasal Naloxone Hydrogel - TipRanks
Polyrizon’s intranasal naloxone hydrogel shows promising test results By Investing.com - Investing.com Canada
Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal Naloxone Hydrogel Program - The Manila Times
[6-K] Polyrizon Ltd. Current Report (Foreign Issuer) | PLRZ SEC FilingForm 6-K - Stock Titan
Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal ... - Enidnews.com
Polyrizon (Nasdaq: PLRZ) shows rapid permeation in intranasal naloxone hydrogel preclinical studies - Stock Titan
Polyrizon Ltd trading halted, news pending - MSN
Earnings Update: Is Polyrizon Ltd stock a buy on dipsJuly 2025 Action & Real-Time Stock Price Movement Reports - BỘ NỘI VỤ
Polyrizon Ltd. (PLRZ) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Polyrizon completes FDA pre-submission meeting for allergy blocker - Investing.com
Polyrizon Advances PL-14 Nasal Spray with FDA Meeting - TipRanks
Polyrizon completes FDA pre-submission meeting for allergy blocker By Investing.com - Investing.com India
Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray - The Manila Times
Polyrizon completes FDA pre-submission meeting for PL-14 allergy blocker nasal spray - marketscreener.com
Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray - GlobeNewswire Inc.
Top Biotech Stocks To ConsiderDecember 4th - MarketBeat
Small Cap Stocks To Keep An Eye OnDecember 4th - MarketBeat
Top Biotech Stocks To Consider – December 4th - Defense World
Biotech Alert: Searches spiking for these stocks today - TipRanks
This Former Penny Stock Just Doubled for the Second Time This Week. Should You Chase the Rally Here? - Barchart.com
Morning Market Movers: SMX, PRAX, PLRZ, RBRK See Big Swings - RTTNews
Polyrizon Ltd. Announces $4.97 Million Securities Offering - TipRanks
We Think Polyrizon (NASDAQ:PLRZ) Can Afford To Drive Business Growth - Yahoo Finance
Top Medical Stocks To Keep An Eye On – December 2nd - Defense World
Polyrizon (PLRZ) Stock Explodes on Naloxone Hydrogel Breakthrough and PL‑14 Upscaling – What Investors Should Know Now - ts2.tech
Polyrizon Surges: A Game-Changer in Progress? - StocksToTrade
Polyrizon (PLRZ) Stock Doubles on Naloxone Hydrogel Breakthrough and PL‑14 Manufacturing Milestone – What Investors Need to Know on December 4, 2025 - ts2.tech
Why Is Polyrizon Stock Skyrocketing Thursday?Polyrizon (NASDAQ:PLRZ) - Benzinga
Polyrizon (NASDAQ: PLRZ) Soars as Superior Mucoadhesion Naloxone Hydrogel Signals Stronger Real-World Opioid Overdose Reversal Potential - Barchart.com
Polyrizon (NASDAQ: PLRZ) Soars as Superior Mucoadhesion - openPR.com
Polyrizon Stock Skyrockets: What Sparked This Surge? - timothysykes.com
From Lab to Global Impact: Polyrizon's Journey to Potentially Redefining Next-Generation Nasal Protection - The Manila Times
Morning Market Movers: PLRZ, PMI, CBIO, HY See Big Swings - RTTNews
Polyrizon (Nasdaq: PLRZ) scales PL-14 nasal spray output for planned 2026 clinical trials - Stock Titan
PLRZ Stock Price and Chart — NASDAQ:PLRZ - TradingView
Why Did Polyrizon Stock Soar Pre-Market Today? - Stocktwits
Polyrizon completes manufacturing upscaling milestone for nasal spray platform - MSN
Polyrizon Ltd (PLRZ) 財務データ
収益
当期純利益
現金流量
EPS
0.90%
0.71%
大文字化:
|
ボリューム (24 時間):